These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

350 related items for PubMed ID: 17516622

  • 1. Elevated serum bioactive prolactin concentrations in patients with systemic lupus erythematosus are associated with disease activity as disclosed by homologous receptor bioassays.
    Cárdenas-Mondragón G, Ulloa-Aguirre A, Isordia-Salas I, Goffin V, Leaños-Miranda A.
    J Rheumatol; 2007 Jul; 34(7):1514-21. PubMed ID: 17516622
    [Abstract] [Full Text] [Related]

  • 2. Elevated bioactive prolactin levels in systemic lupus erythematosus--association with disease activity.
    Pacilio M, Migliaresi S, Meli R, Ambrosone L, Bigliardo B, Di Carlo R.
    J Rheumatol; 2001 Oct; 28(10):2216-21. PubMed ID: 11669159
    [Abstract] [Full Text] [Related]

  • 3. Application of new homologous in vitro bioassays for human lactogens to assess the actual bioactivity of human prolactin isoforms in hyperprolactinaemic patients.
    Leaños-Miranda A, Cárdenas-Mondragón G, Rivera-Leaños R, Ulloa-Aguirre A, Goffin V.
    Clin Endocrinol (Oxf); 2006 Aug; 65(2):146-53. PubMed ID: 16886952
    [Abstract] [Full Text] [Related]

  • 4. Biologic activity and plasma clearance of prolactin-IgG complex in patients with systemic lupus erythematosus.
    Leaños-Miranda A, Chávez-Rueda KA, Blanco-Favela F.
    Arthritis Rheum; 2001 Apr; 44(4):866-75. PubMed ID: 11315926
    [Abstract] [Full Text] [Related]

  • 5. Serum free prolactin concentrations in patients with systemic lupus erythematosus are associated with lupus activity.
    Leaños-Miranda A, Cárdenas-Mondragón G.
    Rheumatology (Oxford); 2006 Jan; 45(1):97-101. PubMed ID: 16249247
    [Abstract] [Full Text] [Related]

  • 6. Correlation of prolactin serum concentrations with clinical activity and remission in patients with systemic lupus erythematosus. Effect of conventional treatment.
    Vera-Lastra O, Mendez C, Jara LJ, Cisneros M, Medina G, Ariza R, Espinoza LR.
    J Rheumatol; 2003 Oct; 30(10):2140-6. PubMed ID: 14528507
    [Abstract] [Full Text] [Related]

  • 7. Hyperprolactinemia in males with systemic lupus erythematosus.
    Mok CC, Lau CS, Lee KW, Wong RW.
    J Rheumatol; 1998 Dec; 25(12):2357-63. PubMed ID: 9858430
    [Abstract] [Full Text] [Related]

  • 8. Prolactin hormone in juvenile systemic lupus erythematosus: a possible relationship to disease activity and CNS manifestations.
    El-Garf A, Salah S, Shaarawy M, Zaki S, Anwer S.
    J Rheumatol; 1996 Feb; 23(2):374-7. PubMed ID: 8882050
    [Abstract] [Full Text] [Related]

  • 9. Antiprolactin autoantibodies in systemic lupus erythematosus: frequency and correlation with prolactinemia and disease activity.
    Leaños-Miranda A, Pascoe-Lira D, Chávez-Rueda KA, Blanco-Favela F.
    J Rheumatol; 2001 Jul; 28(7):1546-53. PubMed ID: 11469460
    [Abstract] [Full Text] [Related]

  • 10. Molecular heterogeneity of prolactin in the plasma of patients with systemic lupus erythematosus.
    Cruz J, Aviña-Zubieta A, Martínez de la Escalera G, Clapp C, Lavalle C.
    Arthritis Rheum; 2001 Jun; 44(6):1331-5. PubMed ID: 11407692
    [Abstract] [Full Text] [Related]

  • 11. No correlation between prolactin levels and clinical activity in patients with systemic lupus erythematosus.
    Buskila D, Lorber M, Neumann L, Flusser D, Shoenfeld Y.
    J Rheumatol; 1996 Apr; 23(4):629-32. PubMed ID: 8730116
    [Abstract] [Full Text] [Related]

  • 12. Elevated serum prolactin or elevated prolactin/cortisol ratio are associated with autoimmune processes in systemic lupus erythematosus and other connective tissue diseases.
    Neidhart M.
    J Rheumatol; 1996 Mar; 23(3):476-81. PubMed ID: 8832986
    [Abstract] [Full Text] [Related]

  • 13. Human macroprolactin displays low biological activity via its homologous receptor in a new sensitive bioassay.
    Glezer A, Soares CR, Vieira JG, Giannella-Neto D, Ribela MT, Goffin V, Bronstein MD.
    J Clin Endocrinol Metab; 2006 Mar; 91(3):1048-55. PubMed ID: 16384849
    [Abstract] [Full Text] [Related]

  • 14. Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus.
    Mahmoud RA, El-Gendi HI, Ahmed HH.
    Clin Biochem; 2005 Feb; 38(2):134-41. PubMed ID: 15642275
    [Abstract] [Full Text] [Related]

  • 15. Elevated levels of soluble fractalkine in active systemic lupus erythematosus: potential involvement in neuropsychiatric manifestations.
    Yajima N, Kasama T, Isozaki T, Odai T, Matsunawa M, Negishi M, Ide H, Kameoka Y, Hirohata S, Adachi M.
    Arthritis Rheum; 2005 Jun; 52(6):1670-5. PubMed ID: 15934075
    [Abstract] [Full Text] [Related]

  • 16. Increased levels of serum protein oxidation and correlation with disease activity in systemic lupus erythematosus.
    Morgan PE, Sturgess AD, Davies MJ.
    Arthritis Rheum; 2005 Jul; 52(7):2069-79. PubMed ID: 15986354
    [Abstract] [Full Text] [Related]

  • 17. Anti-prolactin autoantibodies in paediatric systemic lupus erythematosus patients.
    Blanco-Favela F, Quintal MaG, Chavez-Rueda AK, Leaños-Miranda A, Berron-Peres R, Baca-Ruiz V, Lavalle-Montalvo C.
    Lupus; 2001 Jul; 10(11):803-8. PubMed ID: 11789490
    [Abstract] [Full Text] [Related]

  • 18. Anti-prolactin (PRL) autoantibodies suppress PRL bioactivity in patients with macroprolactinaemia.
    Hattori N, Nakayama Y, Kitagawa K, Ishihara T, Saiki Y, Inagaki C.
    Clin Endocrinol (Oxf); 2008 Jan; 68(1):72-6. PubMed ID: 17681026
    [Abstract] [Full Text] [Related]

  • 19. Clinical significance of nailfold capillaroscopy in systemic lupus erythematosus: correlation with endothelial cell activation markers and disease activity.
    Kuryliszyn-Moskal A, Ciolkiewicz M, Klimiuk PA, Sierakowski S.
    Scand J Rheumatol; 2009 Jan; 38(1):38-45. PubMed ID: 18991188
    [Abstract] [Full Text] [Related]

  • 20. Clinical significance of selected endothelial activation markers in patients with systemic lupus erythematosus.
    Kuryliszyn-Moskal A, Klimiuk PA, Ciolkiewicz M, Sierakowski S.
    J Rheumatol; 2008 Jul; 35(7):1307-13. PubMed ID: 18484695
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.